Characteristics of patients registered for pre-ART care
| Characteristics | In care (n=864) N (col %) | Lost (n=307) N (col %) | P values* | Tracked (n=195) N (col %) | Not tracked (n=112) N (col %) | P values† | Found (n=118) N (col %) | Not found (n=77) N (col %) | P values‡ |
| Sex | 0.17 | 0.97 | 0.84 | ||||||
| Male | 258 (30.5%) | 109 (35.5%) | 69 (35.4%) | 72 (64.3%) | 41 (34.7%) | 28 (36.4%) | |||
| Female | 588 (69.5%) | 198 (64.5%) | 126 (64.6%) | 40 (35.7%) | 77 (65.3%) | 49 (63.6%) | |||
| Location | 0.02 | 0.13 | 0.38 | ||||||
| Urban sites | 718 (84.9%) | 207 (67.4%) | 116 (59.5%) | 91 (81.3%) | 66 (55.9%) | 50 (64.9%) | |||
| Rural sites | 128 (15.1%) | 100 (32.6%) | 79 (40.5%) | 21 (18.8%) | 52 (44.1%) | 27 (35.1%) | |||
| Age in years | 0.15 | 0.25 | 0.44 | ||||||
| <20 | 27 (3.2 %) | 18 (5.9 %) | 14 (7.3 %) | 4 (3.6%) | 10 (8.7 %) | 4 (5.3 %) | |||
| 20–29 | 415 (49.2%) | 158 (52.1%) | 96 (50.3%) | 62 (55.4%) | 53 (46.1%) | 43 (56.6%) | |||
| 30–39 | 266 (31.6%) | 86 (28.4%) | 58 (30.4%) | 28 (25%) | 35 (30.4%) | 23 (30.3%) | |||
| 40–49 | 91 (10.8%) | 35 (11.6%) | 22 (11.5%) | 13 (11.6%) | 16 (13.9%) | 6 (7.9 %) | |||
| 50+ | 44 (5.2 %) | 6 (2.0 %) | 1 (0.5 %) | 5 (4.5%) | 1 (0.9 %) | 0 (0.0 %) | |||
| Missing | 3 | 4 | 4 | 0 | 3 | 1 | |||
| CD4 count cell | 0.08 | 0.07 | 0.27 | ||||||
| 350–499 | 137 (18.0%) | 35 (15.6%) | 21 (16.5%) | 14 (14.4%) | 13 (17.8%) | 8 (14.8%) | |||
| 500–749 | 376 (49.4%) | 100 (44.6%) | 53 (41.7%) | 47 (48.5%) | 34 (46.6%) | 19 (35.2%) | |||
| 750+ | 248 (32.6%) | 89 (39.7%) | 53 (41.7%) | 36 (37.1%) | 26 (35.6%) | 27 (50.0%) | |||
| Median (IQR) | 644 (525‒812) | 654 (540‒892) | 659 (553‒918) | 648 (534‒862) | 640 (553‒885) | 734 (565‒946) | |||
| Missing | 85 | 83 | 68 | 15 | 45 | 23 | |||
| Weight (kg) | 0.27 | 0.53 | 0.10 | ||||||
| <50 | 98 (12.5%) | 36 (15.4%) | 19 (14.0%) | 17 (17.3%) | 9 (11.4%) | 10 (17.5%) | |||
| 50 to <60 | 285 (36.5%) | 87 (37.2%) | 48 (35.3%) | 39 (39.8%) | 28 (35.4%) | 20 (35.1%) | |||
| 60 to <70 | 235 (30.0%) | 76 (32.5%) | 45 (33.1%) | 31 (31.6%) | 22 (27.8%) | 23 (40.4%) | |||
| 70+ | 164 (21.0%) | 35 (15.0%) | 24 (17.6%) | 11 (11.2%) | 20 (25.3%) | 4 (7.0%) | |||
| Median (IQR) | 60 (52‒66) | 59 (52‒65) | 60 (52‒65.5) | 58 (52‒65) | 60 (53‒70) | 59 (51‒62) | |||
| Missing | 64 | 73 | 59 | 14 | 39 | 20 |
↵*P value comparing those in care and lost, using Rao-Scott correction to χ2 test to account for clustered sampling. Individuals with missing values excluded from comparison.
↵†P value comparing those selected for tracing and not selected, calculated as described in footnote *.
↵‡P value comparing those successfully traced and those not found, calculated as described in footnote *.
ART, antiretroviral treatment.